Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Share News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Horizon Discovery Expecting 2015 Results To Beat Market Consensus

Mon, 18th Jan 2016 07:44

LONDON (Alliance News) - Horizon Discovery Group PLC on Monday said revenue for the full year 2015 will be higher than market expectations whilst its loss will also be narrower than anticipated.

The international life science tools business said revenue for 2015 is expected to be "at least" 2% higher than the GBP19.8 million market consensus, suggesting revenue will be at least GBP20.2 million. That would represent a 69% rise in revenue compared to the GBP11.9 million generated in 2014.

It will lead to Horizon Discovery's loss before interest, tax, depreciation and amortisation coming in narrower than market estimates, which currently are for a GBP7.7 million loss for 2015.

In addition, Horizon Discovery said it is eligible to receive future research and development milestones of up to GBP208.0 million plus future product royalties, an increase of 32% over the GBP158.0 million in the prior year.

Horizon said revenue growth in 2015 is reflective of strong product and service sales to large pharmaceutical and diagnostic development companies as well as an increasing number of academic customers purchasing from a product inventory that increased to 23,000 from 2,750.

The company's Products division has been "particularly strong" in 2015, with organic revenue more than doubling in the year, driven by strong demand for genetically-defined cell lines and derived molecular diagnostic reagents, it said.

The Services division is also set to report a 65% lift in revenue in 2015, driven by a strong demand for custom gene-editing, genetic screening and drug combination screening projects.

The Leveraged business continues to generate a portfolio of up-front, milestone and product royalty upside as exemplified by the deals announced with two new collaborations signed in 2015 with Redx and Servier, Horizon Discovery said.

"Further, commitments were made to invest up to GBP10.0 million across the following two years in two cutting-edge areas of cancer biology: synthetic lethality and immuno-oncology, which have the potential to deliver significant upside," it said in a statement.

Cash at the end of 2015 stood at GBP25.1 million, a large lift from the GBP18.5 million cash balance reported at the end of 2014.

Horizon will report its full-year results on April 26.

By Joshua Warner; joshuawarner@alliancenews.com; @JoshAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 Dec 2020 10:31

Horizon Discovery Shares Cancelled Following Acquisition By PerkinElmer

Horizon Discovery Shares Cancelled Following Acquisition By PerkinElmer

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
15 Dec 2020 19:38

UK TRADING UPDATE SUMMARY: Ruffer Says Portfolio Makes Progress

UK TRADING UPDATE SUMMARY: Ruffer Says Portfolio Makes Progress

Read more
8 Dec 2020 15:51

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2020 15:37

Horizon Discovery Licenses CHOSource To China's Sanyou

Horizon Discovery Licenses CHOSource To China's Sanyou

Read more
2 Nov 2020 14:31

Horizon Discovery Surges As Agrees To Bumper GBP296 Million Takeover

Horizon Discovery Surges As Agrees To Bumper GBP296 Million Takeover

Read more
2 Nov 2020 12:20

PerkinElmer to buy Horizon Discovery in £284m deal

(Sharecast News) - Horizon Discovery shares surged on Monday after it agreed to be bought by PerkinElmer in a deal that values the cell engineering company at around £284m.

Read more
2 Nov 2020 11:01

UK WINNERS & LOSERS SUMMARY: Ocado Shares Up; Big AIM Risers Amid M&A

UK WINNERS & LOSERS SUMMARY: Ocado Shares Up; Big AIM Risers Amid M&A

Read more
17 Aug 2020 13:41

Horizon Discovery Sees Recovery After Covid-19 Hits Academic Research

Horizon Discovery Sees Recovery After Covid-19 Hits Academic Research

Read more
10 Aug 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
29 Jul 2020 15:45

IN BRIEF: Horizon Discovery Land Commercial Deals With TrueBinding

IN BRIEF: Horizon Discovery Land Commercial Deals With TrueBinding

Read more
29 Jul 2020 13:56

IN BRIEF: Horizon Discovery Expects Revenue Decline In First Half

IN BRIEF: Horizon Discovery Expects Revenue Decline In First Half

Read more
22 Jul 2020 16:05

Horizon Discovery restarts efforts towards US offering

(Sharecast News) - Horizon Discovery Group updated the market on its plans for a public offering in the United States on Wednesday, confirming it was restarting its efforts to go ahead with one.

Read more
22 Jul 2020 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
7 Jul 2020 20:32

IN BRIEF: Horizon Discovery Introduces Gene-Editing Cell Lines

IN BRIEF: Horizon Discovery Introduces Gene-Editing Cell Lines

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.